Strawberry-flavoured tablet rolled out for minors living with HIV in Kenya, Uganda

Dolutegravir tablets

Dolutegravir tablets. The paediatric formulation of dolutegravir has been hailed as a game changer in managing the virus in children as it makes treatment easier and cheaper. PHOTO | FILE

Kenya has introduced a strawberry-flavoured tablet for children living with the human immunodeficiency virus (HIV).

The paediatric formulation of dolutegravir, a drug recommended as first-line anti-retroviral for HIV treatment by the World Health Organisation (WHO), has been hailed as a game changer in managing the virus in children as it makes treatment easier and cheaper.